Literature DB >> 7503744

Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro.

K Ishidoh1, E Kominami.   

Abstract

The processing of procathepsin L on the surfaces of physiological glycosaminoglycans, heparan sulfate, chondroitin sulfate, etc., as well as dextran derivatives were studied. All glycosaminoglycans and dextran derivatives including dextran T-500 and DEAE dextran examined in this study accelerated the conversion of procathepsin L to processed cathepsin L in vitro with different time courses. Further, we examined whether procathepsin L digests protein substrates in the presence or absence of the surface materials. Laminin was degraded by both procathepsin L itself and the 31-kDa processed form in the presence of surface materials with the same profiles. In contrast, fibronectin was digested by procathepsin L without processing in the presence of surface materials. The proteolytic profiles of fibronectin by the processed form differed from those by procathepsin L. This is the first evidence that the proform of a cysteine proteinase proteolyzes protein substrates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7503744     DOI: 10.1006/bbrc.1995.2820

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  Who are the proteolytic culprits in vascular disease?

Authors:  W C Parks
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 2.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

3.  Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines.

Authors:  Urska Repnik; Amanda E Starr; Christopher M Overall; Boris Turk
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

4.  Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94.

Authors:  Dhivya R Sudhan; Maria B Rabaglino; Charles E Wood; Dietmar W Siemann
Journal:  Clin Exp Metastasis       Date:  2016-04-07       Impact factor: 5.150

5.  Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.

Authors:  R Coulombe; P Grochulski; J Sivaraman; R Ménard; J S Mort; M Cygler
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

6.  Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells.

Authors:  Liza J Burton; Basil A Smith; Bethany N Smith; Quentin Loyd; Peri Nagappan; Danielle McKeithen; Catera L Wilder; Manu O Platt; Tamaro Hudson; Valerie A Odero-Marah
Journal:  Carcinogenesis       Date:  2015-06-10       Impact factor: 4.944

Review 7.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

8.  Cathepsin L increased level upon Ras mutants expression: the role of p38 and p44/42 MAPK signaling pathways.

Authors:  Lorena Urbanelli; Francesco Trivelli; Luisa Ercolani; Eleonora Sementino; Alessandro Magini; Brunella Tancini; Raffaella Franceschini; Carla Emiliani
Journal:  Mol Cell Biochem       Date:  2010-06-04       Impact factor: 3.396

9.  Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.

Authors:  Vineet Sangar; Cory C Funk; Ulrike Kusebauch; David S Campbell; Robert L Moritz; Nathan D Price
Journal:  Mol Cell Proteomics       Date:  2014-07-05       Impact factor: 5.911

10.  The role of NH4Cl and cysteine proteases in Human Papillomavirus type 16 infection.

Authors:  Sarah A Dabydeen; Patricio I Meneses
Journal:  Virol J       Date:  2009-07-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.